CNN, North Korea: May 12, 2016 — Experts say it’s clear North Korea is seeking to exploit US President Donald Trump’s crackdown on immigration in order to convince more Americans that it’s a safer place to live.
But did the Kim Jong Un regime use the President’s pledge to roll back immigration laws as part of its cunning plan to import US weapons?
Experts tell CNN there is considerable evidence that North Korea has commissioned an entirely new generation of deadly technology.
Whether directed at the US or not, it could have led to a joint North Korean-US project to develop the medium-range KN-08 missile.
The Chinese-owned Sinojia Technology Company of Shenyang in Liaoning province last month began exporting its newest test missile — the KN-08 — via shipments that appear to have flown from China to an Asian port.
“Until now [it’s] only been tested once and flown on a carrier in September 2018 to not identify China,” says Rob Kall, president of California-based research and development consultancy GlobalSecurity.org.
Other intelligence and political sources told CNN the new missile is already undergoing military tests in China.
He said Sinojia’s alleged links to North Korea make it unlikely the company conducted its product transfers without Pyongyang’s approval.
The 2018 test flight of the KN-08 missile, complete with decoy and launch system, shows a distance of 4,056 miles and a flight speed of 6,250 miles per hour.
The KN-08’s flight tests would have taken two days, according to the most recent report from the Center for Strategic and International Studies.
Kall told CNN the launch was also consistent with North Korea conducting exercises in the Asian runways and it would be very unusual for the country to exercise a new missile based on testing a display model.
Covid Vaccine — a French vaccine company — shares a relationship with a North Korean pharmaceutical company, according to the New York Times.
The Times says since July 2012, the health care company — called NGC Trading — has used a medical laboratory in Shenyang to test Covid flu vaccines before importing them into China.
The two companies share a cash and patent licensing agreement that pays $30,000 a month in “transfers,” according to a 2015 letter to the US Treasury Department by Ceva Logistics, which shares a parent company with Covid, and Dr. David Karoly, chief executive of Covid Vaccine.
More stringent reporting requirements following tougher UN sanctions did not trigger any enforcement, according to the Times.
“The most significant evidence that the Administration should consider is the ongoing use of Covid vaccines imported from NGC Trading for US military preparation purposes,” Kevin DuMaine, with the German Marshall Fund of the United States, wrote in a blog post .
DuMaine said that it had been possible to purchase large batches of Flu strain B from Covid, since it was marketed for emergency preparedness. The vaccine is harmless to humans but has been shown to be a dangerous weapon in the hands of terrorist organizations.
“The CDC regularly conducts flu surveillance through regular shipments of those vaccines to the National Fluspect Advisory Center,” said Dr. Jonathan White, the CDC’s director of the Influenza Division.
In his letter to Treasury Department, Karoly said the company’s contract with NGC Trading had ended in late 2012 and the rest of Covid’s business with the Chinese company was “extremely small”—$10,000 a month.
While the export licenses had expired, Karoly says it is possible the licenses were renewed in subsequent months.
“If any licenses have expired, it is within their discretion to renew them,” he told CNN.
“They can also be cancelled,” said DuMaine.
CNN has contacted the Treasury Department for clarification.
In December, Vice President Mike Pence said during an interview with the BBC that the administration would pursue comprehensive sanctions and “ultimately” look at “vetting all imports and exports from North Korea.”